News & Perspective

Jul 13, 2011

Jul 13, 2011

Study: Adjuvanted H1N1 vaccines had little effect on GBS risk

(CIDRAP News) – A five-country study from Europe indicates that the use of adjuvanted vaccines against the pandemic H1N1 influenza virus probably did not increase the risk of Guillain-Barre syndrome (GBS), but the investigators could not firmly rule out a slightly greater chance of suffering the paralytic condition.

Jan 11, 2011

Jan 11, 2011

European study says H1N1 vaccine offered good protection

(CIDRAP News) – In the largest study of its kind so far to assess how well 2009 H1N1 vaccines performed in the pandemic setting, new findings from seven European countries showed they provided good protection, a result that mirrors early clinical studies.

Oct 26, 2010

Oct 26, 2010

French study profiles ICU patients with H1N1

(CIDRAP News) – A thorough surveillance study from France reinforces findings from other countries about obesity and delayed antiviral treatment as risk factors for severe 2009 H1N1 influenza, while indicating that the pandemic put a greater burden on intensive care units (ICUs) than seasonal flu typically does.

Pages

by country

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»